July 14, 2015 The Predictive Safety Testing Consortium: Safety Biomarkers, Collaboration, and Qualification
April 13, 2015 Critical Path Institute Secures Regulatory Support For Skeletal Muscle Safety Biomarkers FDA and EMA Letters of Support Suggest Valuable Research Potential TUCSON, Ariz., April 8, 2015 – The Critical Path Institute (C
April 28, 2014 Nonclinical Safety Biomarkers of Drug-induced Vascular Injury: Current Status and Blueprint for the Future
May 24, 2013 Leading US and European Medical Public-Private Partnerships Announce Agreement The Predictive Safety Testing Consortium (PSTC) led by the Critical Path Institute (C-Path) and the Safer and Faster Evidence-base
March 2, 2013 Opportunities and Challenges of Safety Biomarker Qualification: Perspectives from the Predictive Safety Testing Consortium
April 25, 2012 Tucson institute plays critical cancer role Re: the April 19 article “Vast study advances breast cancer fight.”
